|
|
 |
I'm training to be an engineer buy aygestin baikal-pharmacy com The 15-year survival data showed no significant difference between groups (HR 1.02, 95% CI 0.97-1.08). Stratified by cancer grade, the 10-year survival showed a slight but nonsignificant advantage for finasteride in men with low-grade prostate cancer and virtually no difference among men with high-grade disease.
2021-4-26 3:47:40 |
|
|
|
